We are live on ! Find out more
CIP

Champlain Investment Partners Portfolio holdings

AUM $7.88B
1-Year Est. Return 6.82%
This Fund
S&P 500
This Quarter Est. Return
+9.14%
1 Year Est. Return
+6.82%
3 Year Est. Return
+32.7%
5 Year Est. Return
+41.26%
10 Year Est. Return
+331.36%
AUM
$21B
AUM Growth
+$1.82B
Cap. Flow
+$406M
Cap. Flow %
1.93%
Top 10 Hldgs %
18.08%
Holding
144
New
8
Increased
70
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
STE icon
Steris
STE
+$339M
2
PLAN
Anaplan, Inc.
PLAN
+$138M
3
CSGP icon
CoStar Group
CSGP
+$86M
4
MRVI icon
Maravai LifeSciences
MRVI
+$67.7M
5
LESL icon
Leslie's
LESL
+$67.2M

Sector Composition

Rank Sector Weight
1 Healthcare 24.84%
2 Technology 20.7%
3 Industrials 14.5%
4 Consumer Staples 12.97%
5 Financials 12.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ESE icon
101
ESCO Technologies
ESE
$7.77B
$75.5M 0.36%
804,375
+627,080
+354% +$63.2M
PLNT icon
102
Planet Fitness
PLNT
$4.45B
$75.1M 0.36%
998,080
+185,180
+23% +$14.7M
IOSP icon
103
Innospec
IOSP
$2.09B
$74.4M 0.35%
821,190
+12,200
+2% +$1.21M
CBU icon
104
Community Bank
CBU
$3.39B
$73.2M 0.35%
968,240
-77,915
-7% -$6.14M
JRVR icon
105
James River Group Holdings
JRVR
$219M
$72.2M 0.34%
1,923,595
+576,750
+43% +$23M
ENV
106
DELISTED
ENVESTNET, INC.
ENV
$67.1M 0.32%
883,965
-290
-0% -$21.3K
WST icon
107
West Pharmaceutical
WST
$23.7B
$66.9M 0.32%
186,425
-107,320
-37% -$35.5M
CSW
108
CSW Industrials
CSW
$4.44B
$65.3M 0.31%
551,175
+178,410
+48% +$22.8M
SUMO
109
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
$65.3M 0.31%
3,160,240
+2,844,440
+901% +$54.9M
SXI icon
110
Standex International
SXI
$3.33B
$62.5M 0.3%
658,465
+470
+0.1% +$45.6K
PLMR icon
111
Palomar
PLMR
$3.79B
$62.2M 0.3%
824,720
+111,285
+16% +$8.02M
VCYT icon
112
Veracyte
VCYT
$4.45B
$62.2M 0.3%
1,555,560
+1,001,895
+181% +$42.8M
OM icon
113
Outset Medical
OM
$86.4M
$59.2M 0.28%
79,027
+40,668
+106% +$31.1M
QLYS icon
114
Qualys
QLYS
$4.76B
$58.1M 0.28%
577,510
+545
+0.1% +$55.5K
ROCK icon
115
Gibraltar Industries
ROCK
$1.28B
$55.1M 0.26%
722,230
+555,830
+334% +$45.9M
CVBF icon
116
CVB Financial
CVBF
$4.02B
$54.2M 0.26%
2,630,915
+9,550
+0.4% +$209K
UTZ icon
117
Utz Brands
UTZ
$1.24B
$53.1M 0.25%
2,436,335
+725,760
+42% +$18.1M
BWIN
118
Baldwin Insurance Group
BWIN
$2.75B
$52.5M 0.25%
1,969,905
+949,445
+93% +$25.7M
GABC icon
119
German American Bancorp
GABC
$1.93B
$48.4M 0.23%
1,301,160
+53,150
+4% +$2.23M
LUNG icon
120
Pulmonx
LUNG
$52.8M
$47M 0.22%
1,065,015
+592,270
+125% +$25.8M
ABCM
121
DELISTED
Abcam PLC
ABCM
$46.5M 0.22%
2,441,085
+2,384,085
+4,183% +$47.5M
SYBT icon
122
Stock Yards Bancorp
SYBT
$2.6B
$45.8M 0.22%
899,267
+5,530
+0.6% +$286K
BMTC
123
DELISTED
Bryn Mawr Bank Corp
BMTC
$42.4M 0.2%
1,005,175
+5,160
+0.5% +$236K
GGG icon
124
Graco
GGG
$13.2B
$39.5M 0.19%
+522,324
New +$39.2M
CENTA icon
125
Central Garden & Pet Co Class A
CENTA
$2.43B
$38.9M 0.18%
1,005,469
+436,623
+77% +$17.9M

Similar funds

Champlain Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Champlain Investment Partners held 144 positions worth $21B, up 9.5% from $19.2B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Champlain Investment Partners's Q2 2021 filing shows 8 new, 70 increased, 59 reduced and 5 closed positions. Its largest new stake was Steris: 1,685,437 shares worth $348M. The largest sale was Cantel Medical Corporation, an estimated $320M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Industrials.

  • Champlain Investment Partners's largest Q2 2021 buy was Steris: 1,685,437 shares worth $348M.
  • Champlain Investment Partners added most to Maravai LifeSciences in Q2 2021, an estimated $67.7M increase.
  • Champlain Investment Partners's biggest Q2 2021 reduction was Ulta Beauty, cutting an estimated $63.1M.
  • Champlain Investment Partners fully exited Cantel Medical Corporation in Q2 2021, selling an estimated $320M.
  • Champlain Investment Partners's ten largest holdings make up 18% of its $21B portfolio in Q2 2021.
  • Champlain Investment Partners opened 8 new positions and closed 5 in Q2 2021.
  • Champlain Investment Partners's portfolio value rose 9.5% quarter-over-quarter to $21B.

Based on Champlain Investment Partners's 13F filing for Q2 2021, filed 12 Aug 2021.